TNFRSF10B Antikörper
Kurzübersicht für TNFRSF10B Antikörper (ABIN376980)
Target
Alle TNFRSF10B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Human DR5
-
Produktmerkmale
- Rabbit Anti-Human DR5-UNLB
-
Aufreinigung
- Purified
-
Immunogen
- Recombinant DR5
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
-
- Applications: FC - Quality tested WB , ICC
- Working Dilutions: Flow Cytometry Purified (UNLB) antibody 3 g/106 cells For flow cytometry, the suggested use of these reagents is in a final volume of 100 L Immunoblotting Purified (UNLB) antibody 2 g/mL Immunocytochemistry Purified (UNLB) antibody 2 g/mL
-
Kommentare
-
induction of apoptosis
-
Probenmenge
- 0,2 mL
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Konzentration
- 0.5 mg/mL
-
Buffer
- 0.1 mg of purified immunoglobulin in 0.2 mL of borate buffered saline, pH 8.2. No preservatives or amine-containing buffer salts added
-
Konservierungsmittel
- Without preservative
-
Handhabung
- Each reagent is stable for the period shown on the bottle label if stored as directed.
-
Lagerung
- 4 °C
-
Informationen zur Lagerung
- Store at 2-8°C
-
-
- TNFRSF10B (Tumor Necrosis Factor Receptor Superfamily, Member 10b (TNFRSF10B))
-
Andere Bezeichnung
- DR5
-
Hintergrund
- DR5, also known as TRAIL-R2, TRICK2 and KILLER, is a widely expressed type I membrane member of the tumor necrosis (TNF) receptor family. Members of this family contain multiple cysteine-rich repeats in their extracellular domain and while the cytoplasmic region is less conserved, they do contain an intracellular 80 AA motif known as the ‘death domain' (DD). DR5 is a receptor for the cytotoxic ligand TRAIL which induces apoptosis and it is the cytoplasmic DD that is responsible for transducing the death process. DR5 has also been shown to activate NF- λB.
-
Pathways
- p53 Signalweg, Apoptose, Positive Regulation of Endopeptidase Activity
Target
-